Artivion (AORT)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$25.57-0.20%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · AORT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 471.5 | 441.3 | 388.5 | 354.0 | 313.8 | 298.8 | 253.2 | 276.2 | 262.8 | 189.7 | 180.4 | 145.9 | 144.6 | 140.8 | 131.7 | 119.6 |
| Total Revenues | — | — | — | — | — | 298.8 | 253.2 | 276.2 | 262.8 | 189.7 | 180.4 | 145.9 | 144.6 | 140.8 | 131.7 | 119.6 |
| Cost of Revenues | 168.0 | 157.1 | 139.8 | 124.8 | 111.3 | 101.3 | 85.4 | 93.2 | 89.9 | 61.1 | 61.5 | 55.2 | 53.4 | 50.4 | 46.7 | 43.8 |
| Gross Profit | 303.5 | 284.2 | 248.8 | 229.2 | 202.5 | 197.5 | 167.8 | 183.0 | 173.0 | 128.6 | 118.9 | 90.7 | 91.3 | 90.4 | 85.0 | 75.8 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 254.8 | 226.5 | 181.5 | 209.0 | 157.4 | 169.8 | 141.1 | 143.0 | 140.6 | 101.2 | 91.5 | 74.9 | 73.8 | 68.1 | 65.1 | 57.3 |
| R&D Expenses | 35.1 | 31.0 | 28.5 | 28.7 | 38.9 | 35.5 | 24.2 | 23.0 | 23.1 | 19.5 | 13.4 | 10.4 | 8.7 | 8.5 | 7.3 | 6.9 |
| Operating Income | 20.6 | 33.7 | 38.9 | 5.7 | 6.2 | 8.1 | 2.4 | 17.0 | 9.3 | 8.0 | 21.8 | 5.4 | 8.8 | 13.8 | 12.6 | 11.6 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 26.6 | 34.3 | 25.3 | 18.2 | 16.9 | 16.7 | 14.9 | 15.8 | 4.9 | 3.0 | 0.1 | — | 0.1 | 0.2 | 0.1 |
| Interest & Investment Income | 1.1 | 0.8 | 1.5 | 1.1 | 0.1 | 0.1 | 0.2 | 0.7 | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | 24.2 | 18.1 | 16.8 | 16.5 | 14.2 | 15.6 | 4.7 | 2.9 | 0.0 | — | 0.1 | 0.2 | 0.1 |
| EBT, Incl. Unusual Items | 2.2 | 14.8 | (7.5) | (21.6) | (15.0) | (14.8) | (17.2) | 1.6 | (6.4) | 3.6 | 18.4 | 5.9 | 8.7 | 23.3 | 12.1 | 11.5 |
| Income Tax Expense | 5.4 | 5.0 | 5.8 | 9.1 | 4.2 | 0.0 | (0.5) | (0.1) | (3.6) | (0.1) | 7.6 | 1.9 | 1.4 | 7.1 | 4.1 | 4.1 |
| Net Income | ||||||||||||||||
| Net Income | (3.2) | 9.8 | (13.4) | (30.7) | (19.2) | (14.8) | (16.7) | 1.7 | (2.8) | 3.7 | 10.8 | 4.0 | 7.3 | 16.2 | 7.9 | 7.4 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.07) | 0.22 | (0.32) | (0.75) | (0.48) | (0.38) | (0.44) | 0.05 | (0.08) | 0.11 | 0.33 | 0.14 | 0.26 | 0.59 | 0.29 | 0.26 |
| Diluted EPS | (0.07) | 0.21 | (0.32) | (0.75) | (0.48) | (0.38) | (0.44) | 0.05 | (0.08) | 0.11 | 0.32 | 0.14 | 0.25 | 0.57 | 0.28 | 0.26 |
| Revenue per Share | 9.71 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.12 | 0.11 | 0.05 | — |
| Basic Weighted Avg Shares | 48.5 | 45.3 | 41.7 | 40.7 | 40.0 | 39.0 | 37.9 | 37.1 | 36.4 | 33.0 | 31.9 | 27.7 | 27.4 | 26.9 | 27.0 | 27.4 |
| Diluted Weighted Avg Shares | 48.5 | 47.2 | 41.7 | 40.7 | 40.0 | 39.0 | 37.9 | 37.9 | 36.4 | 34.2 | 32.8 | 28.5 | 28.3 | 27.7 | 27.4 | 27.8 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 56.2 | 63.1 | 28.8 | 28.6 | 32.1 | 23.2 | 35.4 | 27.4 | 17.7 | 30.2 | 11.2 | 14.9 | 19.7 | 18.2 | 16.6 |
| EBIT | 20.6 | 33.7 | 38.9 | 5.7 | 6.2 | 8.1 | 2.4 | 17.0 | 9.3 | 8.0 | 21.8 | 5.4 | 8.8 | 13.8 | 12.6 | 11.6 |
| Effective Tax Rate | 241.7% | — | — | -42.2% | -28.1% | -0.0% | 2.9% | -4.6% | 55.6% | -4.0% | 41.5% | 31.7% | 15.9% | 30.6% | 34.1% | 35.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.